Malaria deaths rise by 69,000 in 2020 due to COVID-19 disruptions, says WHO

In total over 627,000 people globally – most of them babies in the poorest parts of Africa – were killed by malaria last year compared with 558,000 in 2019, the WHO said in its annual malaria report.

Reuters
December 07, 2021 / 07:38 AM IST

Healthcare disruptions linked to the coronavirus pandemic helped malaria kill 69,000 more people in 2020 than the previous year, but a worst-case scenario was averted, the World Health Organization said.

In total over 627,000 people globally – most of them babies in the poorest parts of Africa – were killed by malaria last year compared with 558,000 in 2019, the WHO said in its annual malaria report.

The number eclipses the 224,000 people reported to have died from the coronavirus in Africa since the start of the pandemic.

About two thirds of the additional malaria deaths in 2020 were due to coronavirus restrictions disrupting prevention, diagnosis and treatment of malaria, the WHO said.

But efforts to maintain health services despite the challenges meant Sub-Saharan Africa did not see the doubling of malaria deaths in 2020 that the WHO had warned was a possibility.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Instead, the number of deaths in the region rose 12% compared with 2019, according to WHO data.

"Thanks to urgent and strenuous efforts we can claim that the world has succeeded in averting the worst-case scenario of malaria deaths," said Pedro Alonso, director of the WHO’s global malaria programme.

Experts hope the fight against malaria might gain considerable ground following the WHO’s recommendation in October that RTS,S – or Mosquirix – a vaccine developed by British drugmaker GlaxoSmithKline should be widely given to children in Africa.

"With increased funding, access to life-saving tools, and robust innovation in new tools to stay ahead of the evolving mosquito and parasite, we can accelerate transformative action and end malaria within a generation," said Abdourahmane Diallo, chief executive of the RBM Partnership to End Malaria advocacy group.

"We are now at a critical juncture, and I urge global leaders for renewed commitment and investment," he said in a statement.
Reuters
Tags: #coronavirus #Covid-19 #malaria #WHO #World News
first published: Dec 7, 2021 07:39 am